Cancer/Tumor Profiling Market

1
Cancer/Tumor Profiling Market
One-Stop Shop for Business Information
2
Summary
Cancer/Tumor profiling is a promising market and
is witnessing significant growth in the
healthcare industry. It is poised to grow rapidly
in a range of application areas, including
biomarker discovery and prognosis. The global
cancer/tumor profiling market is valued at 14.99
billion in 2013 and is expected to reach 35.03
billion by 2018. A list of tests (for example,
Barium X-ray, Blood tests, Bone marrow,
Cystoscopy, Lumbar puncture) is available, used
for diagnosing specific types of cancer. Also,
there are different treatment options for cancer,
including chemotherapy, hormone therapy, surgery,
radiotherapy, bisphosphonates, bone marrow and
stem cell transplants, and biological therapies.
Despite the availability of different treatment
options, profiling a cancer/tumor, that is,
knowledge about a patients cancer/tumor profile
may identify genomic alterations that will help
the physician to guide the patient to a systemic
therapy with a higher likelihood of success. 
3
This will rule out those that are unlikely to be
successful, on an individual basis, thereby
minimizing the trial and error process. Every
cancer cell has got its own pattern of active
genes and proteins therefore, molecular
profiling tests for a number of different
biomarkers in the DNA of a tissue sample will
assist in better diagnosing and staging the
cancer on an individual basis. This provides the
doctors with better information to develop a
personalized treatment plan for a patient, which
is known as personalized medicine. There are
quite a number of research groups working on
diverse applications of cancer/tumor profiling
targeting different cancer types, particularly in
studying key target molecules involved in the
pathogenesis. Hundreds of research articles have
been published and a lot of patents granted and
filed for this field of biology.
4
The cancer/tumor profiling market is analyzed
both in terms of qualitative, that is,
technological and quantitative, that is, revenue
and perspectives. The technological analysis
includes discussion on the advantages and
capabilities of cancer/tumor profiling
technologies and the various applications where
cancer/tumor profiling can find a strong position
in the healthcare industry. The market revenue
analysis includes market segmentation and the
expected market position by 2018, with the
projected growth rate. The cancer/tumor profiling
market is classified by geography, applications,
technologies, and segment types. The technologies
section is further segmented into Next-Generation
Sequencing, Quantitative PCR, Immunohistochemistry
, FISH/CISH, and Microarray. Though personalized
medicine is highlighted as the prime application
area of cancer/tumor profiling, there are many
opportunities in Diagnostics, Biomarker
Discovery, Prognosis, and Research applications.
5
Besides a discussion on the properties and
advantages of cancer/tumor profiling in the
technological analysis, the basics on the
correlation of cancer with genomics, proteomics,
Metabolomics, and epigenetics are also discussed.
Further, the research network including academic
universities and biotech companies with their
research contributions are also provided. The
complete value chain of the cancer/tumor
profiling market is schematically represented and
the significance of each stakeholder has been
briefed. Apart from the technological and market
analysis, the investor climate has been assessed
by tracking the complete investor network and
collecting data on funds/grants and investments
made towards the cancer/tumor profiling. Insights
on current and future technological investment
trends have also been discussed.
6
Table Of Content

1. INTRODUCTION 20
2. EXECUTIVE SUMMARY 27
3. CANCER/TUMOR PROFILING TECHNOLOGY LANDSCAPE 31
4. CANCER/TUMOR PROFILING RESEARCH PORTFOLIO 51
5. VALUE CHAIN ANALYSIS 54
6. MARKET LANDSCAPE ANALYSIS 63
7. TECHNOLOGY ADOPTION AND DEVELOPMENT POTENTIAL, BY
   GEOGRAPHY 114
8. TECHNOLOGY INVESTMENT ANALYSIS 122
9.  COMPETITIVE LANDSCAPE ANALYSIS 136
10. PATENT ANALYSIS 141
11.  ANALYST INSIGHTS AND RECOMMENDATIONS 144

7

• To know more
• Cancer/Tumor Profiling Market

Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 Email id
info_at_bharatbook.com